Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Operations And Comprehensive Loss

v3.23.1
Consolidated Statements Of Operations And Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Net revenue $ 48,462 $ 39,188 $ 22,780
Cost of revenue 32,551 22,659 16,607
Gross profit 15,911 16,529 6,173
Operating expenses:      
Sales and marketing 21,675 15,339 11,242
General and administrative 12,309 11,258 9,772
Engineering and development 7,265 6,048 3,695
Patent Litigation Mark-to-Market 0 315 0
Total operating expenses 41,249 32,960 24,709
Loss from operations (25,338) (16,431) (18,536)
Loss on foreign currency transactions (438) (452) (21)
Interest expense, net (2,749) (2,224) (2,359)
Gain on debt forgiveness 0 3,014 0
Other income, net 0 0 4,215
Non-operating gain (loss), net (3,187) 338 1,835
Loss before income tax provision (28,525) (16,093) (16,701)
Income tax (provision) benefit (109) (65) (128)
Net loss (28,634) (16,158) (16,829)
Other comprehensive loss items:      
Foreign currency translation adjustments (110) (238) 316
Comprehensive loss (28,744) (16,396) (16,513)
Net loss (28,634) (16,158) (16,829)
Deemed dividend on convertible preferred stock (217) (546) (17,378)
Net loss attributable to common stockholders $ (28,851) $ (16,704) $ (34,207)
Net loss per share attributable to common stockholders:      
Basic $ (4.16) $ (2.83) $ (13.99)
Diluted $ (4.16) $ (2.83) $ (13.99)
Shares used in the calculation of net loss per share:      
Basic 6,930 5,910 2,445
Diluted 6,930 5,910 2,445